-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on CVS Health, Lowers Price Target to $125

Benzinga·08/06/2026 15:00:58
Listen to the news
Evercore ISI Group analyst Elizabeth Anderson maintains CVS Health (NYSE:CVS) with a Outperform and lowers the price target from $130 to $125.